Therapy

Electrotherapy (Electrotherapy)

Main article: Electrotherapy (Electrotherapy)

History

2024: Global Digital Therapeutic Systems Market Growth by 10% to $4.86 Billion

In 2024, costs in the global digital therapeutic systems market amounted to $4.86 billion. This is 10% more compared to 2023, when expenses in this area were estimated at $4.41 billion. Such data are reflected in the Market Research Future study, the results of which are presented in mid-March 2025.

Digital therapies are software tools and various devices that help treat diseases by monitoring patients and collecting data on their body's vital signs. The primary goal is to engage people in personalized disease treatment or prevention programs that promote behavioral and psychological change, maintain motivation, and improve lifestyles.

One of the main components of the digital therapeutic systems ecosystem are mobile apps and smartphones tablets that offer features such as medication reminders, symptom control and access to information resources. The integration of such applications with wearable gadgets allows for real-time data delivery to both patients and healthcare providers, which promotes collaborative health management.

Healthcare workers are increasingly integrating digital therapies into standard treatment regimens, the study says. The development of the sector is facilitated by the introduction of telemedicine platforms, as well as artificial intelligence and machine learning tools. AI algorithms help analyze the collected health data and form individual treatment plans. Wearable devices also play an important role by providing patients with real-time monitoring capabilities to help identify dangerous abnormalities.

Analysts call the increase in the prevalence of chronic diseases, including diabetes, obesity, cardiovascular ailments and mental disorders, an important market driver. As the population ages, health problems become more common: this stimulates the demand for effective and affordable health care. Digital therapeutic devices provide patients with innovative tools to help monitor their condition, monitor symptoms and stick to treatment plans.

The study authors highlight five key therapeutic segments: diabetes management, mental health control, cardiovascular disease, neurological disorders, and addiction management. In 2024, the first of these areas accounted for $1.2 billion, the second - $1.5 billion. Solutions for monitoring cardiovascular diseases brought in $1 billion. Revenue in the segments of neurological disorders and addiction management amounted to $0.86 billion and $0.3 billion, respectively. Geographically, North America became the leader in 2024 with $2.15 billion. This is followed by Europe with an estimate of $1.3 billion, and the Asia-Pacific region closes the top three with $0.85 billion. Among the significant players in the market are:

• Zebra Health;
• Gain Life;
• Livongo;
• Sanofi;
• Johnson and Johnson;
• WellDoc;
• Apple;
• Pear Therapeutics;
• Happify Health;
• MyStrength;
• Bluebird Bio;
• DarioHealth;
• Omada Health;
• AstraZeneca;
• Novartis.

Market Research Future analysts believe that in the future, the CAGR in the market under consideration will be 10.11%. As a result, by 2035, costs on a global scale could rise to $14.01 billion.^[1]

Notes